Adenovirus mediated expression “in vivo” of the chemokine receptor CXCR1
A major hurdle in the structural analysis of membrane proteins is the expression of a functional and homogeneous form of the protein. Except for rhodopsin, most G protein-coupled receptors (GPCRs) are endogenously expressed at very low levels. Heterologous expression of GPCRs in bacteria, yeast, insect cells or mammalian cell lines often yields proteins with large amounts of misfolded proteins and heterogeneous posttranslational modifications. Here, we report a novel mammalian “in vivo” system for the expression of the chemokine receptor CXCR1. This receptor was expressed in liver of mice infected with adenovirus encoding CXCR1. Liver plasma membranes from infected mice displayed high-levels of 125I-labeled human interleukin-8 (IL-8) binding. The pharmacological profile of the recombinant CXCR1 expressed “in vivo” was similar to those expressed in neutrophils. We found that the incorporation of the detergent solubilized CXCR1 into phospholipid vesicles in the presence of Gi/Go proteins is required for the reconstitution of 125I-IL-8 binding. On the basis of the presence of the several endogenous His residues and glycosylation moieties in CXCR1 we fractionated the detergent-solubilized plasma membranes by employing Ni- and Concanavalin A-based chromatography. Fractions enriched with CXCR1 were monitored by 125I-IL-8-bound to the receptor and Western blots with anti-CXCR1 antibodies. This robust expression system could be readily applied for the expression of GPCRs and other eukaryotic membrane proteins.
KeywordsChemokines GPCR Adenovirus Receptors Reconstitution Protein expression
Green fluorescence protein
Critical micellar concentration
Human granulocyte chemotactic protein 2
Melanoma growth-stimulating activity
We are grateful to Professor David Konkel of our Department of Biochemistry and Molecular Biology for editing and valuable discussions. This work was supported by the National Institutes of Health R01 GM081798 and the Welch Foundation.
- 1.Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Kuhn P, Weis WI, Kobilka BK, Stevens RC (2007) High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 318:1258–1265. doi: 10.1126/science.1150577 PubMedCrossRefGoogle Scholar
- 6.Kypreos KE, van Dijk KW, van Der Zee A, Havekes LM, Zannis VI (2001) Domains of apolipoprotein E contributing to triglyceride and cholesterol homeostasis in vivo. Carboxy l-terminal region 203–299 promotes hepatic very low density lipoprotein triglyceride secretion. J Biol Chem 276:19778–19786. doi: 10.1074/jbc.M100418200 PubMedCrossRefGoogle Scholar
- 14.Rasmussen SG, Choi HJ, Rosenbaum DM, Kobilka TS, Thian FS, Edwards PC, Burghammer M, Ratnala VR, Sanishvili R, Fischetti RF, Schertler GF, Weis WI, Kobilka BK (2007) Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 450:383–387. doi: 10.1038/nature06325 PubMedCrossRefGoogle Scholar
- 16.Reeves PJ, Callewaert N, Contreras R, Khorana HG (2002) Structure and function in rhodopsin: high-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line. Proc Natl Acad Sci USA 99:13419–13424. doi: 10.1073/pnas.212519299 PubMedCrossRefGoogle Scholar